Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours - PubMed (original) (raw)

Review

Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours

Katarzyna Stępień et al. Med Oncol. 2016 Sep.

Abstract

Hyperbaric oxygen (HBO) therapy is widely used as an adjunctive treatment for various pathological states, predominantly related to hypoxic and/or ischaemic conditions. It also holds promise as an approach to overcoming the problem of oxygen deficiency in the poorly oxygenated regions of the neoplastic tissue. Occurrence of local hypoxia within the central areas of solid tumours is one of the major issues contributing to ineffective medical treatment. However, in anti-cancer therapy, HBO alone gives a limited curative effect and is typically not applied by itself. More often, HBO is used as an adjuvant treatment along with other therapeutic modalities, such as radio- and chemotherapy. This review outlines the existing data regarding the medical use of HBO in cancer treatment, with a particular focus on the use of HBO in the treatment of brain tumours. We conclude that the administration of HBO can provide many clinical benefits in the treatment of tumours, including management of highly malignant gliomas. Applied immediately before irradiation, it is safe and well tolerated by patients, causing rare and limited side effects. The results obtained with a combination of HBO/radiotherapy protocol proved to be especially favourable compared to radiation treatment alone. HBO can also increase the cytostatic effect of certain drugs, which may render standard chemotherapy more effective. The currently available data support the legitimacy of conducting further research on the use of HBO in the treatment of malignancies.

Keywords: Cancer; Chemotherapy; Glioblastoma; Hyperbaric oxygen therapy; Hypoxia; Radiation therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Similar articles

• Radiotherapy after hyperbaric oxygenation in malignant gliomas.
  Chen JR, Xu HZ, Ding JB, Qin ZY. Chen JR, et al. Curr Med Res Opin. 2015 Nov;31(11):1977-84. doi: 10.1185/03007995.2015.1082988. Epub 2015 Sep 28. Curr Med Res Opin. 2015. PMID: 26414129 Review.
• A narrative review of adjuvant therapy for glioma: hyperbaric oxygen therapy.
  Xue T, Ding JS, Li B, Cao DM, Chen G. Xue T, et al. Med Gas Res. 2021 Oct-Dec;11(4):155-157. doi: 10.4103/2045-9912.318861. Med Gas Res. 2021. PMID: 34213498 Free PMC article. Review.
• Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro.
  Zembrzuska K, Ostrowski RP, Matyja E. Zembrzuska K, et al. Oncol Rep. 2019 May;41(5):2703-2716. doi: 10.3892/or.2019.7064. Epub 2019 Mar 14. Oncol Rep. 2019. PMID: 30896865 Free PMC article.
• A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas.
  Beppu T, Kamada K, Nakamura R, Oikawa H, Takeda M, Fukuda T, Arai H, Ogasawara K, Ogawa A. Beppu T, et al. J Neurooncol. 2003 Jan;61(2):161-70. doi: 10.1023/a:1022169107872. J Neurooncol. 2003. PMID: 12622455 Clinical Trial.
• Old but new methods in radiation oncology: hyperbaric oxygen therapy.
  Ogawa K, Kohshi K, Ishiuchi S, Matsushita M, Yoshimi N, Murayama S. Ogawa K, et al. Int J Clin Oncol. 2013 Jun;18(3):364-70. doi: 10.1007/s10147-013-0537-6. Epub 2013 Mar 5. Int J Clin Oncol. 2013. PMID: 23463521 Review.

Cited by

• Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma.
  Arpa D, Parisi E, Ghigi G, Cortesi A, Longobardi P, Cenni P, Pieri M, Tontini L, Neri E, Micheletti S, Ghetti F, Monti M, Foca F, Tesei A, Arienti C, Sarnelli A, Martinelli G, Romeo A. Arpa D, et al. Front Oncol. 2021 Mar 30;11:643469. doi: 10.3389/fonc.2021.643469. eCollection 2021. Front Oncol. 2021. PMID: 33859944 Free PMC article.
• Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours.
  Adant S, Shah GM, Beauregard JM. Adant S, et al. Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):907-921. doi: 10.1007/s00259-019-04499-x. Epub 2019 Sep 6. Eur J Nucl Med Mol Imaging. 2020. PMID: 31492995 Review.
• Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.
  Lyu F, Li Y, Yan Z, He Q, Cheng L, Zhang P, Liu B, Liu C, Song Y, Xing Y. Lyu F, et al. J Transl Med. 2022 May 10;20(1):202. doi: 10.1186/s12967-022-03398-4. J Transl Med. 2022. PMID: 35538543 Free PMC article.
• Hyperbaric Oxygen Prevents Cognitive Impairments in Mice Induced by D-Galactose by Improving Cholinergic and Anti-apoptotic Functions.
  Chen C, Huang L, Nong Z, Li Y, Chen W, Huang J, Pan X, Wu G, Lin Y. Chen C, et al. Neurochem Res. 2017 Apr;42(4):1240-1253. doi: 10.1007/s11064-016-2166-8. Epub 2017 Jan 11. Neurochem Res. 2017. PMID: 28078611
• Reaction of the Hippocampal Microglia to Hyperbaric Oxygen.
  Kirik OV, Alekseeva OS, Tsyba DL, Korzhevskii DE. Kirik OV, et al. Bull Exp Biol Med. 2022 Sep;173(5):655-659. doi: 10.1007/s10517-022-05607-y. Epub 2022 Oct 10. Bull Exp Biol Med. 2022. PMID: 36210418 Free PMC article.

References

1. 1. Jain KK. Physical, physiological, and biochemical aspects of hyperbaric oxygenation. In: Jain KK, editor. Textbook of hyperbaric medicine. Germany: Hogrefe & Huber; 2009. pp. 9–20.
2. 1. Daruwalla J, Christophi C. Hyperbaric oxygen therapy for malignancy: a review. World J Surg. 2006;30(12):2112–2131. doi: 10.1007/s00268-006-0190-6. - DOI - PubMed
3. 1. Gill AL, Bell CN. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. QJM. 2004;97(7):385–395. doi: 10.1093/qjmed/hch074. - DOI - PubMed
4. 1. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med. 1996;334(25):1642–1648. doi: 10.1056/NEJM199606203342506. - DOI - PubMed
5. 1. Chaves JC, Fagundes DJ, Simoes Mde J, Bertoletto PR, Oshima CT, Taha MO, et al. Hyperbaric oxygen therapy protects the liver from apoptosis caused by ischemia-reperfusion injury in rats. Microsurgery. 2009;29(7):578–583. doi: 10.1002/micr.20664. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations